Insider Selling: Cartesian Therapeutics, Inc. (NASDAQ:RNAC) CFO Sells 4,028 Shares of Stock

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) CFO Blaine Davis sold 4,028 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $16.83, for a total value of $67,791.24. Following the completion of the transaction, the chief financial officer now directly owns 94,811 […]

Leave a Reply

Your email address will not be published.

Previous post Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO Kenneth Allen Myszkowski Sells 27,167 Shares
Next post Milos Miljkovic Sells 932 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Stock